Global Paclitaxel Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
ReportID: 543387
|
Published Date: 11/08/2021
|
No. of Pages: 162
|
Categories: Life Sciences
|
Format : 
The global Paclitaxel market was valued at 9.28 Million USD in 2020 and will grow with a CAGR of 8.44% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg. The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
By Market Verdors:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
By Types:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
By Applications:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg. The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
By Market Verdors:
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
By Types:
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
By Applications:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paclitaxel Revenue
1.4 Market Analysis by Type
1.4.1 Global Paclitaxel Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Natural Paclitaxel API
1.4.3 Semi-synthetic Paclitaxel API
1.5 Market by Application
1.5.1 Global Paclitaxel Market Share by Application: 2022-2027
1.5.2 Ovarian Cancer
1.5.3 Cervical Cancer
1.5.4 Breast Cancer
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Paclitaxel Market
1.8.1 Global Paclitaxel Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Paclitaxel Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Paclitaxel Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Paclitaxel Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Paclitaxel Sales Volume Market Share by Region (2016-2021)
3.2 Global Paclitaxel Sales Revenue Market Share by Region (2016-2021)
3.3 North America Paclitaxel Sales Volume
3.3.1 North America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.3.2 North America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Paclitaxel Sales Volume
3.4.1 East Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Paclitaxel Sales Volume (2016-2021)
3.5.1 Europe Paclitaxel Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Paclitaxel Sales Volume (2016-2021)
3.6.1 South Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Paclitaxel Sales Volume (2016-2021)
3.7.1 Southeast Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Paclitaxel Sales Volume (2016-2021)
3.8.1 Middle East Paclitaxel Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Paclitaxel Sales Volume (2016-2021)
3.9.1 Africa Paclitaxel Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Paclitaxel Sales Volume (2016-2021)
3.10.1 Oceania Paclitaxel Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Paclitaxel Sales Volume (2016-2021)
3.11.1 South America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.11.2 South America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Paclitaxel Sales Volume (2016-2021)
3.12.1 Rest of the World Paclitaxel Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Paclitaxel Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Paclitaxel Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Paclitaxel Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Paclitaxel Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Paclitaxel Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Paclitaxel Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Paclitaxel Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Paclitaxel Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Paclitaxel Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Paclitaxel Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Paclitaxel Sales Volume Market Share by Type (2016-2021)
14.2 Global Paclitaxel Sales Revenue Market Share by Type (2016-2021)
14.3 Global Paclitaxel Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Paclitaxel Consumption Volume by Application (2016-2021)
15.2 Global Paclitaxel Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Paclitaxel Business
16.1 Phyton
16.1.1 Phyton Company Profile
16.1.2 Phyton Paclitaxel Product Specification
16.1.3 Phyton Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 ScinoPharm
16.2.1 ScinoPharm Company Profile
16.2.2 ScinoPharm Paclitaxel Product Specification
16.2.3 ScinoPharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Novasep
16.3.1 Novasep Company Profile
16.3.2 Novasep Paclitaxel Product Specification
16.3.3 Novasep Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Samyang
16.4.1 Samyang Company Profile
16.4.2 Samyang Paclitaxel Product Specification
16.4.3 Samyang Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Polymed
16.5.1 Polymed Company Profile
16.5.2 Polymed Paclitaxel Product Specification
16.5.3 Polymed Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 TAPI (Teva)
16.6.1 TAPI (Teva) Company Profile
16.6.2 TAPI (Teva) Paclitaxel Product Specification
16.6.3 TAPI (Teva) Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Fresenius-kabi
16.7.1 Fresenius-kabi Company Profile
16.7.2 Fresenius-kabi Paclitaxel Product Specification
16.7.3 Fresenius-kabi Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Huiang biopharma
16.8.1 Huiang biopharma Company Profile
16.8.2 Huiang biopharma Paclitaxel Product Specification
16.8.3 Huiang biopharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Southpharma
16.9.1 Southpharma Company Profile
16.9.2 Southpharma Paclitaxel Product Specification
16.9.3 Southpharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Yunnan Hande
16.10.1 Yunnan Hande Company Profile
16.10.2 Yunnan Hande Paclitaxel Product Specification
16.10.3 Yunnan Hande Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Hainan Yew Pharm
16.11.1 Hainan Yew Pharm Company Profile
16.11.2 Hainan Yew Pharm Paclitaxel Product Specification
16.11.3 Hainan Yew Pharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Jiangsu Yew Biotechnology
16.12.1 Jiangsu Yew Biotechnology Company Profile
16.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Specification
16.12.3 Jiangsu Yew Biotechnology Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Paclitaxel Manufacturing Cost Analysis
17.1 Paclitaxel Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Paclitaxel
17.4 Paclitaxel Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Paclitaxel Distributors List
18.3 Paclitaxel Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Paclitaxel (2022-2027)
20.2 Global Forecasted Revenue of Paclitaxel (2022-2027)
20.3 Global Forecasted Price of Paclitaxel (2016-2027)
20.4 Global Forecasted Production of Paclitaxel by Region (2022-2027)
20.4.1 North America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.3 Europe Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.7 Africa Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.9 South America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Paclitaxel Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Paclitaxel by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Paclitaxel by Country
21.2 East Asia Market Forecasted Consumption of Paclitaxel by Country
21.3 Europe Market Forecasted Consumption of Paclitaxel by Countriy
21.4 South Asia Forecasted Consumption of Paclitaxel by Country
21.5 Southeast Asia Forecasted Consumption of Paclitaxel by Country
21.6 Middle East Forecasted Consumption of Paclitaxel by Country
21.7 Africa Forecasted Consumption of Paclitaxel by Country
21.8 Oceania Forecasted Consumption of Paclitaxel by Country
21.9 South America Forecasted Consumption of Paclitaxel by Country
21.10 Rest of the world Forecasted Consumption of Paclitaxel by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paclitaxel Revenue
1.4 Market Analysis by Type
1.4.1 Global Paclitaxel Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Natural Paclitaxel API
1.4.3 Semi-synthetic Paclitaxel API
1.5 Market by Application
1.5.1 Global Paclitaxel Market Share by Application: 2022-2027
1.5.2 Ovarian Cancer
1.5.3 Cervical Cancer
1.5.4 Breast Cancer
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Paclitaxel Market
1.8.1 Global Paclitaxel Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Paclitaxel Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Paclitaxel Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Paclitaxel Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Paclitaxel Sales Volume Market Share by Region (2016-2021)
3.2 Global Paclitaxel Sales Revenue Market Share by Region (2016-2021)
3.3 North America Paclitaxel Sales Volume
3.3.1 North America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.3.2 North America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Paclitaxel Sales Volume
3.4.1 East Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Paclitaxel Sales Volume (2016-2021)
3.5.1 Europe Paclitaxel Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Paclitaxel Sales Volume (2016-2021)
3.6.1 South Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Paclitaxel Sales Volume (2016-2021)
3.7.1 Southeast Asia Paclitaxel Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Paclitaxel Sales Volume (2016-2021)
3.8.1 Middle East Paclitaxel Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Paclitaxel Sales Volume (2016-2021)
3.9.1 Africa Paclitaxel Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Paclitaxel Sales Volume (2016-2021)
3.10.1 Oceania Paclitaxel Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Paclitaxel Sales Volume (2016-2021)
3.11.1 South America Paclitaxel Sales Volume Growth Rate (2016-2021)
3.11.2 South America Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Paclitaxel Sales Volume (2016-2021)
3.12.1 Rest of the World Paclitaxel Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Paclitaxel Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Paclitaxel Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Paclitaxel Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Paclitaxel Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Paclitaxel Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Paclitaxel Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Paclitaxel Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Paclitaxel Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Paclitaxel Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Paclitaxel Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Paclitaxel Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Paclitaxel Sales Volume Market Share by Type (2016-2021)
14.2 Global Paclitaxel Sales Revenue Market Share by Type (2016-2021)
14.3 Global Paclitaxel Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Paclitaxel Consumption Volume by Application (2016-2021)
15.2 Global Paclitaxel Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Paclitaxel Business
16.1 Phyton
16.1.1 Phyton Company Profile
16.1.2 Phyton Paclitaxel Product Specification
16.1.3 Phyton Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 ScinoPharm
16.2.1 ScinoPharm Company Profile
16.2.2 ScinoPharm Paclitaxel Product Specification
16.2.3 ScinoPharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Novasep
16.3.1 Novasep Company Profile
16.3.2 Novasep Paclitaxel Product Specification
16.3.3 Novasep Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Samyang
16.4.1 Samyang Company Profile
16.4.2 Samyang Paclitaxel Product Specification
16.4.3 Samyang Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Polymed
16.5.1 Polymed Company Profile
16.5.2 Polymed Paclitaxel Product Specification
16.5.3 Polymed Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 TAPI (Teva)
16.6.1 TAPI (Teva) Company Profile
16.6.2 TAPI (Teva) Paclitaxel Product Specification
16.6.3 TAPI (Teva) Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Fresenius-kabi
16.7.1 Fresenius-kabi Company Profile
16.7.2 Fresenius-kabi Paclitaxel Product Specification
16.7.3 Fresenius-kabi Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Huiang biopharma
16.8.1 Huiang biopharma Company Profile
16.8.2 Huiang biopharma Paclitaxel Product Specification
16.8.3 Huiang biopharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Southpharma
16.9.1 Southpharma Company Profile
16.9.2 Southpharma Paclitaxel Product Specification
16.9.3 Southpharma Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Yunnan Hande
16.10.1 Yunnan Hande Company Profile
16.10.2 Yunnan Hande Paclitaxel Product Specification
16.10.3 Yunnan Hande Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Hainan Yew Pharm
16.11.1 Hainan Yew Pharm Company Profile
16.11.2 Hainan Yew Pharm Paclitaxel Product Specification
16.11.3 Hainan Yew Pharm Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Jiangsu Yew Biotechnology
16.12.1 Jiangsu Yew Biotechnology Company Profile
16.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Specification
16.12.3 Jiangsu Yew Biotechnology Paclitaxel Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Paclitaxel Manufacturing Cost Analysis
17.1 Paclitaxel Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Paclitaxel
17.4 Paclitaxel Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Paclitaxel Distributors List
18.3 Paclitaxel Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Paclitaxel (2022-2027)
20.2 Global Forecasted Revenue of Paclitaxel (2022-2027)
20.3 Global Forecasted Price of Paclitaxel (2016-2027)
20.4 Global Forecasted Production of Paclitaxel by Region (2022-2027)
20.4.1 North America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.3 Europe Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.7 Africa Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.9 South America Paclitaxel Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Paclitaxel Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Paclitaxel by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Paclitaxel by Country
21.2 East Asia Market Forecasted Consumption of Paclitaxel by Country
21.3 Europe Market Forecasted Consumption of Paclitaxel by Countriy
21.4 South Asia Forecasted Consumption of Paclitaxel by Country
21.5 Southeast Asia Forecasted Consumption of Paclitaxel by Country
21.6 Middle East Forecasted Consumption of Paclitaxel by Country
21.7 Africa Forecasted Consumption of Paclitaxel by Country
21.8 Oceania Forecasted Consumption of Paclitaxel by Country
21.9 South America Forecasted Consumption of Paclitaxel by Country
21.10 Rest of the world Forecasted Consumption of Paclitaxel by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:11/08/2021
Base Year:
Historical Data:
No of Pages:162
Price
Global Paclitaxel Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
